129 related articles for article (PubMed ID: 28992668)
1. [Spontaneous Remission of Everolimus-Induced Interstitial Lung Disease in Metastatic Renal Cell Carcinoma : An Autopsy Case Report].
Kurokawa M; Naito S; Ichiyanagi O; Kabasawa T; Kurota Y; Sakurai T; Nishida H; Kawazoe H; Kato T; Nagaoka A; Yamakawa M; Tsuchiya N
Hinyokika Kiyo; 2017 Sep; 63(9):377-380. PubMed ID: 28992668
[TBL] [Abstract][Full Text] [Related]
2. Granuloma-forming interstitial pneumonia occurring one year after the start of everolimus therapy.
Saito Y; Kunugi S; Suzuki Y; Narita K; Miura Y; Minegishi Y; Kimura G; Kondo Y; Azuma A; Fukuda Y; Gemma A
Intern Med; 2013; 52(2):263-7. PubMed ID: 23318860
[TBL] [Abstract][Full Text] [Related]
3. Patterns of interstitial lung disease during everolimus treatment in patients with metastatic renal cell carcinoma.
Mizuno R; Asano K; Mikami S; Nagata H; Kaneko G; Oya M
Jpn J Clin Oncol; 2012 May; 42(5):442-6. PubMed ID: 22438405
[TBL] [Abstract][Full Text] [Related]
4. [Rechallenge of everolimus for metastatic renal cell carcinoma after recovery from grade 3 interstitial lung disease: a case report].
Utsunomiya N; Kono Y; Matsumoto K; Matsumoto T; Nakagawa A; Tsunemori H; Okada T; Muguruma K; Kawakita M
Hinyokika Kiyo; 2014 Jan; 60(1):25-8. PubMed ID: 24594769
[TBL] [Abstract][Full Text] [Related]
5. Interstitial lung disease during targeted therapy in metastatic renal cell carcinoma: a case series from three centres.
Ivanyi P; Fuehner T; Adam M; Eichelberg C; Herrmann E; Merseburger AS; Ganser A; Grünwald V
Med Oncol; 2014 Sep; 31(9):147. PubMed ID: 25134914
[TBL] [Abstract][Full Text] [Related]
6. [A Case of Renal Cell Carcinoma with High Everolimus Blood Concentrations and Hyperglycemia Due to Everolimus-Induced Hepatic Dysfunction].
Takasaki S; Kikuchi M; Kawasaki Y; Ito A; Arai Y; Yamaguchi H; Mano N
Gan To Kagaku Ryoho; 2017 Jan; 44(1):87-89. PubMed ID: 28174388
[TBL] [Abstract][Full Text] [Related]
7. Two cases of everolimus-associated interstitial pneumonia in patients with renal cell carcinoma.
Akata K; Yatera K; Ishimoto H; Kozaki M; Yamasaki K; Nagata S; Nishida C; Yoshida T; Kawanami T; Matsumoto T; Mukae H
Intern Med; 2011; 50(24):3013-7. PubMed ID: 22185995
[TBL] [Abstract][Full Text] [Related]
8. Adverse event profile and dose modification of everolimus for advanced renal cell carcinoma in real-world Japanese clinical practice.
Nozawa M; Nonomura N; Ueda T; Nishimura K; Kanayama HO; Miki T; Nakatani T; Tomita Y; Azuma H; Yoshioka T; Tsujihata M; Uemura H
Jpn J Clin Oncol; 2013 Nov; 43(11):1132-8. PubMed ID: 23999768
[TBL] [Abstract][Full Text] [Related]
9. A Phase II Study of Everolimus Plus Oral Prednisone in Patients with Metastatic Renal Cell Cancer.
Lolli C; Gallà V; Schepisi G; Barone D; Burgio SL; Maugeri A; Vertogen B; Amadori D; De Giorgi U
Oncologist; 2017 Jul; 22(7):784-e74. PubMed ID: 28546463
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological Characteristics of Everolimus-Associated Interstitial Lung Disease: A Single-Center Consecutive Analysis.
Saito Y; Terasaki Y; Kashiwada T; Tanaka T; Takei H; Kimura G; Kondo Y; Kawagoe T; Matsushita A; Noro R; Minegishi Y; Kamio K; Seike M; Gemma A
J Nippon Med Sch; 2024 May; 91(2):207-217. PubMed ID: 38233124
[TBL] [Abstract][Full Text] [Related]
11. A case of pneumocystis pneumonia associated with everolimus therapy for renal cell carcinoma.
Saito Y; Nagayama M; Miura Y; Ogushi S; Suzuki Y; Noro R; Minegishi Y; Kimura G; Kondo Y; Gemma A
Jpn J Clin Oncol; 2013 May; 43(5):559-62. PubMed ID: 23423809
[TBL] [Abstract][Full Text] [Related]
12. Post-marketing observational study of everolimus in patients with unresectable or metastatic renal cell carcinoma in Japan.
Akaza H; Kurihara R; Katsura A; Harumiya M; Ushida N
Jpn J Clin Oncol; 2019 Oct; 49(10):956-964. PubMed ID: 31135920
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and Safety of Sequential Use of Everolimus in Patients With Metastatic Renal Cell Carcinoma Previously Treated With Bevacizumab With or Without Interferon Therapy: Results From the European AVATOR Study.
Thiery-Vuillemin A; Theodore C; Jacobasch L; Schmitz J; Papandreou C; Guillot A; Emmanouilides C; Slimane K; Kelkouli N; Kim S; Nguyen Tan Hon T
Clin Genitourin Cancer; 2015 Jun; 13(3):231-8. PubMed ID: 25456838
[TBL] [Abstract][Full Text] [Related]
14. Complete response in metastatic renal cell carcinoma after radiotherapy and everolimus: a clinical case and review of the literature.
Detti B; Francolini G; Becherini C; Olmetto E; Giacomelli I; Scartoni D; Greto D; Baldazzi V; Simontacchi G; Meattini I; Livi L
J Chemother; 2016 Oct; 28(5):432-4. PubMed ID: 27376403
[TBL] [Abstract][Full Text] [Related]
15. Prospective Study of Drug-induced Interstitial Lung Disease in Advanced Breast Cancer Patients Receiving Everolimus Plus Exemestane.
Willemsen AECAB; Tol J; van Erp NP; Jonker MA; de Boer M; Meek B; de Jong PC; van Moorsel C; Gerritsen WR; Grutters JC; van Herpen CML
Target Oncol; 2019 Aug; 14(4):441-451. PubMed ID: 31325105
[TBL] [Abstract][Full Text] [Related]
16. [Management of side effects of everolimus treatment for metastatic renal cell carcinoma].
Mikami K; Hongo F; Miki T
Hinyokika Kiyo; 2012 Nov; 58(11):647-50. PubMed ID: 23254794
[TBL] [Abstract][Full Text] [Related]
17. Everolimus-induced activation of latent
Jeon SY; Yhim HY; Lee NR; Song EK; Kwak JY; Yim CY
Korean J Intern Med; 2017 Mar; 32(2):365-368. PubMed ID: 26837008
[No Abstract] [Full Text] [Related]
18. Successful everolimus treatment in a patient with advanced pancreatic neuroendocrine tumor who developed everolimus-induced interstitial lung disease on two occasions: a case report.
Nakayama Y; Ikeda M; Kojima M; Goto K; Hara M; Okuyama H; Takahashi H; Ohno I; Shimizu S; Mitsunaga S; Okusaka T
Chemotherapy; 2013; 59(1):74-8. PubMed ID: 23867634
[TBL] [Abstract][Full Text] [Related]
19. Sunitinib-related interstitial pneumonia after treatment with temsirolimus: a case of possible recall phenomenon.
Kushima H; Ishii H; Kadota J
Int J Urol; 2014 Apr; 21(4):420-1. PubMed ID: 24168290
[TBL] [Abstract][Full Text] [Related]
20. Everolimus-induced pneumonitis associates with favourable outcome in patients with metastatic renal cell carcinoma.
Penttilä P; Donskov F; Rautiola J; Peltola K; Laukka M; Bono P
Eur J Cancer; 2017 Aug; 81():9-16. PubMed ID: 28586749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
